Durvalumab for untreated PD-L1-positive metastatic non-small-cell lung cancer [ID3762]

  • Discontinued
  • GID-TA10633
Timelines for this appraisal are to be confirmed. Further information regarding the scheduling of this appraisal will be available in due course.